J&J And Amgen Cut Staff In U.S. | April 20, 2009 Issue - Vol. 87 Issue 16 | Chemical & Engineering News
Volume 87 Issue 16 | p. 20 | Concentrates
Issue Date: April 20, 2009

J&J And Amgen Cut Staff In U.S.

Department: Business

Johnson & Johnson will eliminate about 900 positions in its Ortho-McNeil-Janssen Pharmaceuticals division. The cutbacks, which will mainly affect U.S. salespeople, represent about 6% of the division's staff. Meanwhile, Amgen will consolidate its clinical manufacturing operations in Thousand Oaks, Calif., eliminating 100 positions at a facility in Bothell, Wash. The Bothell facility, which came with Amgen's 2002 acquisition of Immunex, will continue to house oncology research in conjunction with a center in Seattle.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment